San Diego 2019

Improving the Cataract Patient Experience: Minimizing Pain and Inflammation while Reducing the Need for Topical Drops

Supported By: EyePoint Pharmaceuticals, ImprimisRx, Ocular Therapeutix and Omeros Corporation

 

San Diego

Saturday, May 4, 2019


City/State/Country: San Diego, CA USA
Venue: San Diego Convention Center
Room Location: 20D
Registration: 5:00 PM - 5:30 PM
Program: 5:30 PM - 6:30 PM

Program Chairs
Eric D. Donnenfeld, MD
Edward J. Holland, MD

Faculty
Alice T. Epitropoulos, MD
Denise M. Visco, MD
William F. Wiley, MD

 

Preliminary Program

5:30 PM Welcome and Introduction - Eric D. Donnenfeld, MD

5:40 PM The Impact of Pain and Inflammation: Who is at Risk, Who is Nonadherent and Why It Matters - Edward J. Holland, MD

5:50 PM Current and Emerging Approaches to Minimize Topical Drops

  •  Intracameral dexamethasone - Eric D. Donnenfeld, MD
  • Punctal plug dexamethasone - Alice T. Epitropoulos, MD
  • Nanotechnology loteprednol - Edward J. Holland, MD
  • Intracameral ketorolac/phenylephrine - Denise M. Visco, MD, MBA
  • Compounded medications - William F. Wiley, MD

6:15 PM Panel Discussion: Evolving Reimbursement Models, Passthrough and Their Impact on Access to New Technology to Control Pain and Inflammation

6:25 PM Concluding remarks - Edward J. Holland, MD